Health Care & Life Sciences » Pharmaceuticals | Sunflower Pharmaceuticals Group Co. Ltd.

Sunflower Pharmaceuticals Group Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
439
1,799
969
1,164
1,186
1,472
Total Accounts Receivable
235
364
496
590
574
691
Inventories
347
351
537
648
797
814
Other Current Assets
66
42
62
101
67
72
Total Current Assets
1,086
2,555
2,064
2,502
2,625
3,050
Net Property, Plant & Equipment
761
920
1,227
1,225
1,262
1,357
Total Investments and Advances
2
2
2
2
3
3
Intangible Assets
228
223
432
434
501
567
Other Assets
2
3
3
5
4
6
Total Assets
2,099
3,733
3,765
4,224
4,470
5,059
ST Debt & Current Portion LT Debt
618
661
255
347
129
Accounts Payable
187
163
276
334
368
Income Tax Payable
41
44
40
38
57
Other Current Liabilities
126
187
279
351
397
Total Current Liabilities
972
1,054
849
1,071
952
Long-Term Debt
99
158
1
1
1
Deferred Taxes
16
25
11
33
44
Other Liabilities
154
-
-
-
-
Total Liabilities
1,230
1,217
878
1,094
983
Common Equity (Total)
828
2,216
2,449
2,637
2,993
Total Shareholders' Equity
828
2,216
2,449
2,637
2,993
Total Equity
869
2,280
2,610
2,804
3,162
Liabilities & Shareholders' Equity
2,099
3,733
3,765
4,224
4,470
Accumulated Minority Interest
41
63
161
167
169
Non-Equity Reserves
-
237
277
325
326

About Sunflower Pharmaceuticals Group Co.

View Profile
Address
No. 18 Donghu Road, Jizhong Area
Harbin Heilongjiang 150078
China
Employees -
Website http://www.kuihuayaoye.com
Updated 07/08/2019
Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceutical products. It focuses on proprietary Chinese medicines, chemical drugs, bio-pharmaceuticals, and tonic health care products. Its products include children's medication, digestive system medication, respiratory and cold medicine, gynecological drugs, rheumatism bone disease medication, and cardiovascular and cerebrovascular drugs.